Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04316182
Title Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) (ACTION)
Acronym ACTION
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomedica
Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.